Mechanical Thrombectomy for Acute Ischemic Stroke in Patients with Malignancy: A Systematic Review.

Per the available evidence, MT appears to be a safe treatment option for CPs. It is still unclear whether the 90-day mortality and outcome rates are more heavily influenced by the malignancy and not the intervention itself, so MT can be considered in CPs with prospects of a good functional recovery, undertaking an individualized approach.